Evaluation of the ctDNA LUNAR Test in an Average Coloscopy

Evaluation of the ctDNA LUNAR Test in an Average Coloscopy

Brief description of study

To see if a blood test called GuardantLUNAR-2 can help detect colorectal cancer or other diseases. The main goal of ECLIPSE is to collect health information and blood samples from people who are at average risk for colorectal cancer and are scheduled to have a colonoscopy screening test.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Coloscopy
  • Age: Between 45 Years - 84 Years
  • Gender: All

Male or Female Age 45-84

Updated on 09 Mar 2024. Study ID: 843123
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center